Imm: Exam IV Flashcards

1
Q

Topic 13

Immunodeficiencies

Definition: Pathogen ____ and ____ of the immune system

Can be…

  • Primary (____) immunodeficiencies
  • Secondary (____) immunodeficiencies
Bank: 
subversion
evasion
acquired
inherited
A

Immunodeficiencies

Definition: Pathogen evasion and subversion of the immune system

Can be…

  • Primary (inherited) immunodeficiencies
  • Secondary (acquired) immunodeficiencies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Topic 13

Mechanisms Used by Pathogens to Evade the Immune System:

  • Genetic ___
  • Mutation and ___
    • Antigenic drift: ____
    • Antigenic shift: ____
  • Gene ____
  • Hiding: viral ____
  • ____antigen
Bank:
rearrangement
recombination
epidemics
variation
pandemics
latency
super
A

Mechanisms Used by Pathogens to Evade the Immune System:

  • Genetic variation
  • Mutation and recombination
    • Antigenic drift: epidemics
    • Antigenic shift: pandemics
  • Gene rearrangement
  • Hiding: viral latency
  • Superantigen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Topic 13

Pathogen Evasion:
Genetic _____

  • Strategy used by _____ to evade a host’s immune response to maximize their probability of being transmitted to a fresh ___ or to continue growing.
  • S. pnuemoniae has at least 90 different ____
Bank:
serotypes
pathogens
host
variation
A

Pathogen Evasion:
Genetic Variation

  • Strategy used by pathogens to evade a host’s immune response to maximize their probability of being transmitted to a fresh host or to continue growing.
  • S. pnuemoniae has at least 90 different serotypes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Topic 13

Pathogen Evasion: Gene Mutation

  • Influenza antigenic ___: high mutation rate of hemagglutinin (H) and neuraminidase (N) genes changes the surface antigens every year (____)
  • __ H variants and __ N variants (H1N1).
  • Original antigenic sin
Bank:
epidemics
drift
9
13
A

Pathogen Evasion: Gene Mutation

  • Influenza antigenic drift: high mutation rate of hemagglutinin (H) and neuraminidase (N) genes changes the surface antigens every year – epidemics
  • 13 H variants and 9 N variants (H1N1).
  • Original antigenic sin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Topic 13

Pathogen Evasion: Genome Recombination

  • Influenza antigenic ____: influenza RNA genomes recombination between different -____ (e.g. human vs avian), happens every 10-50 years, and causes ____ diseases. Spanish flu killed millions of people

Bank:
pandemic
species
shift

A

Pathogen Evasion: Genome Recombination

  • Influenza antigenic shift: influenza RNA genomes recombination between different species (e.g. human vs avian), happens every 10-50 years, and causes pandemic diseases. Spanish flu killed millions of people
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Topic 13

Pathogen Evasion:
Gene Rearrangement

  • African _____ (a protozoan) has a life cycle between human and insects
  • Only one variant can express at a time by gene conversion _____
  • ____ immune responses and dominant/minority changes and leaves immune complex depositions in
    the nerve system and causes ____ sickness
Bank:
sleeping
rearrangement
repeated
trypanosome
A

Pathogen Evasion:
Gene Rearrangement

  • African Trypanosome (a protozoan) has a life cycle between human and insects
  • Only one variant can express at a time by gene conversion rearrangement
  • Repeated immune responses and dominant/minority changes and leaves immune complex depositions in
    the nerve system and causes sleeping sickness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Topic 13

Pathogen Evasion: Identity Hiding

  • ____ simplex virus (cause of cold sores) infects ____ cells and then spread to sensory neurons
  • Immune system clears those in ____, but not in the neurons due to viral latency and low of MHC-1 on neurons
  • ____ (sunlight, infection) reactivate the virus and they travel down and reinfect the epithelium
  • Herpesvirus varicella-zoster (____) and Epstein-Barr virus employ a similar strategy
Bank:
epithelium
shingles
herpes
epithelial
stresses
A

Pathogen Evasion: Identity Hiding

  • Herpes simplex virus (cause of cold sores) infects epithelial cells and then spread to sensory neurons
  • Immune system clears those in epithelium, but not in the neurons due to viral latency and low of MHC-1 on neurons
  • Stresses (sunlight, infection) reactivate the virus and they travel down and reinfect the epithelium
  • Herpesvirus varicella-zoster (shingles) and Epstein-Barr virus employ a similar strategy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Topic 13

Pathogen Subversion Weakens the Immune System

  • _____ aureus makes
    staphylococcus superantigen-like protein (SSLP)
  • Blocks ____
  • Inhibits ___ activation

Bank:
phagocytosis
C5
staphylococcus

A

Pathogen Subversion Weakens the Immune System

  • Staphylococcus aureus makes
    staphylococcus superantigen-like protein (SSLP)
  • Blocks phagocytosis
  • Inhibits C5 activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Topic 13

Superantigens

  • _____ superantigen: Soluble protein from bacterium, exotoxins
  • _____ superantigen: membrane proteins produced by some viruses
  • Up to 20% of circulating naïve ____ T cells can be activated and make IL-1, IL-2, TNF-α causing systemic shock
  • Useful _____ immune responses are suppressed
Bank:
adaptive
Endogenous
Exogenous
CD4
A

Superantigens

  • Exogenous superantigen: Soluble protein from bacterium, exotoxins
  • Endogenous superantigen: membrane proteins produced by some viruses
  • Up to 20% of circulating naïve CD4 T cells can be activated and make IL-1, IL-2, TNF-α causing systemic shock
  • Useful adaptive immune responses are suppressed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Topic 13

Inherited Immunodeficiencies

  • Caused by immune gene _
  • 3 types:
    • ____
    • ____
    • ____
Bank:
mutations
recessive
dominant
X-linked
A

Inherited Immunodeficiencies

  • Caused by immune gene mutations
  • 3 types:
    • Dominant
    • Recessive
    • X-linked
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Topic 13

Severe Combined Immunodeficiency (SCID)

X-linked SCID:
- X-Linked Agamaglobulinemia (XLA), Mutant Bruton’s Tyrosine Kinase (Btk), no __ cells

- X-linked hyper IgM syndrome, defect of \_\_\_\_ ligand gene in T cells, no isotype switching, B cells only produce IgM
- IL-2R-γ chain mutation, T cell fails development
Bank:
B
T
CD40
CD80
A

Severe Combined Immunodeficiency (SCID)

X-linked SCID:
- X-Linked Agamaglobulinemia (XLA), Mutant Bruton’s Tyrosine Kinase (Btk), no B cells

- X-linked hyper IgM syndrome, defect of CD40 ligand gene in T cells, no isotype switching, B cells only produce IgM
- IL-2R-γ chain mutation, T cell fails development
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Topic 13

Severe Combined Immunodeficiency (SCID)

Autosomal SCID:
- RAG1/2 mutation (____)

- \_\_\_\_ mutation
- ZAP-70
- FOXN1 mutation, \_\_\_\_ (nude mice)

Bank:
CD3
athymic
Omenn syndrome

A

Severe Combined Immunodeficiency (SCID)

Autosomal SCID:
- RAG1/2 mutation (Omenn syndrome)

- CD3 mutation
- ZAP-70
- FOXN1 mutation, athymic (nude mice)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Topic 13

Gene mutations
affect __ and __
cell development and activation

A

Gene Mutations
Affect T and B
Cell Development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Topic 13

Defects of phagocytes

  • Leukocyte adhesion deficiency (___)
  • Chronic granulomatous disease (___)
  • Glucose-6-phosphate dehydrogenase (___) deficiency
  • Myeloperoxidase deficiency (___)
  • Chediak - Higashi syndrome (___)
Bank: 
CGD
CHS
G6PD
MPOD
LAD
A

Defects of phagocytes

  • Leukocyte adhesion deficiency (LAD)
  • Chronic granulomatous disease (CGD)
  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency
  • Myeloperoxidase deficiency (MPOD)
  • Chediak - Higashi syndrome (CHS)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Topic 13

Complement System Gene Mutations

Classical pathway: deficiency leads to _____ disease

MBL pathway: Deficiency of MBL leads to ____ infections, mainly in childhood

Alternative pathway: deficiency leads to infection with ____ bacteria and Neisseria app. but no immune complex disease

Bank:
bacterial
immune-complex
pyogenic

A

Complement System Gene Mutations

Classical pathway: deficiency leads to immune-complex disease

MBL pathway: Deficiency of MBL leads to bacterial infections, mainly in childhood

Alternative pathway: deficiency leads to infection with pyogenic bacteria and Neisseria app. but no immune complex disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Topic 13

Therapies for Primary Immunodeficiency

  • Replacement of a ___ protein
  • Replacement of a missing or ___ gene
  • Replacement of a missing cell ____ or lineage

Bank:
defective
type
missing

A

Therapies for Primary Immunodeficiency

  • Replacement of a missing protein
  • Replacement of a missing or defective gene
  • Replacement of a missing cell type or lineage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Topic 13

Acquired Immune Deficiency Syndrome (AIDS)

  • Comes from human immunodeficiency virus (___)
  • It is a slow progressing ___ retrovirus, also called ___
  • It infects ___ T cells, macrophages, and dendritic cells
Bank:
HIV
RNA
lentivirus
CD4+
CD8+
A

Acquired Immune Deficiency Syndrome (AIDS)

  • Comes from human immunodeficiency virus (HIV)
  • It is a slow progressing RNA retrovirus, also called lentivirus
  • It infects CD4+ T cells, macrophages, and dendritic cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Topic 13

Human Immunodeficiency Virus (HIV)

  • HIV-1 uses membrane protein ___ and ____ to bind to ___ on target cells (macrophage, DC, TH cells)
  • The entrance of HIV-1 into cells requires the CD4/gp120/gp41 complex bind to a co-receptor
    Chemokine receptor: ___ or ___
  • HIV-1 has two major variants:
    • __ strain
    • __ strain
Bank:
gp120
gp41
CD4
CD8
CCR5
CXCR4
R5
X4
A

Human Immunodeficiency Virus (HIV)

  • HIV-1 uses membrane protein gp120 and gp41 to bind to CD4 on target cells (macrophage, DC, TH cells)
  • The entrance of HIV-1 into cells requires the CD4/gp120/gp41 complex bind to a co-receptor
    Chemokine receptor: CCR5 or CXCR4
  • HIV-1 has two major variants:
    • R5 strain
    • X4 strain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Topic 13

HIV Unleashes ______
Infections

A

HIV Unleashes Opportunistic

Infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Topic 13

Why Can’t the Immune System Completely Eliminate HIV?

1) HIV is ____: RNA to DNA: high ____
2) HIV infects ___ T cells: block immune response
3) Unknown

Bank: 
mutation
retrovirus
CD4+
CD8+
A

Why Can’t the Immune System Completely Eliminate HIV?

1) HIV is retrovirus: RNA to DNA: high mutation
2) HIV infects CD4+ T cells: block immune response
3) Unknown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Topic 13

HIV Infection Differs In Population with Different Genetic Background

  • People with ___ defects are resistant to HIV
  • ___ and ___ polymorphism influences the progress of AIDS

Bank:
CCR5
HLA
KIR

A

HIV Infection Differs In Population with Different Genetic Background

  • People with CCR5 defects are resistant to HIV
  • HLA and KIR polymorphism influences the progress of AIDS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Topic 13

AIDS Treatments

1) Vaccine: ___
2) Inhibitors: partially ____
3) Only two completely cured cases (The ___ patient (Timothy Brown) and The ____ patient ( Adam Castillejo)

Bank:
successful
failed
Berlin
London
A

AIDS Treatments

1) Vaccine: failed
2) Inhibitors: partially successful
3) Only two completely cured cases (The Berlin patient (Timothy Brown) and The London patient ( Adam Castillejo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Topic 14

Hypersensitivity

_____: Immune responses (similar to inflammation reactions) to ______.

______ - the result of secondary immune responses to innocuous environmental antigens.

______ - antigens that elicit allergic reaction.

______ - state of hypersensitivity against harmless environmental antigens.

Bank:
Allergy
Allergic reactions
Allergens
Hypersensitivity
Innocuous antigens
A

Hypersensitivity

Hypersensitivity: Immune responses (similar to inflammation reactions) to innocuous antigens.

Allergic reactions - the result of secondary immune responses to innocuous environmental antigens.

Allergens - antigens that elicit allergic reaction.

Allergy - state of hypersensitivity against harmless environmental antigens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Topic 14

Common sources of Allergens (4)?

A

Respiratory
Circulatory
Digestive tract
Integument

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Topic 14

Types of hypersensitivity

Type I: ___: Depends on mast cells; most common

Type II: ___

Type III: Small _____ system, cannot aggregate to large structure (soluble)

Type IV: Controlled by ___

Bank: 
immunocomplex
IgE
T cells
IgG
A

Types of hypersensitivity

Type I: IgE: Depends on mast cells; most common

Type II: IgG

Type III: Small immunocomplex system, cannot aggregate to large structure (soluble)

Type IV: Controlled by T cells

26
Q

Topic 14

Type I Hypersensitivity

  • ___ mediated sensitivity
  • _____, basophils, a. nonactivated eosinophils
  • Immune responses designed for multicellular _____
  • ____ binding has the highest binding affinity, “irreversible”
  • Mast cells also express _____ ( Inhibitory signal; IgG shots for allergy )
Bank:
parasite infections
Mast cells
IgE/FcεRI
IgE
FcγRIIB
A

Type I Hypersensitivity

  • IgE mediated sensitivity
  • Mast cells, basophils, a. nonactivated eosinophils
  • Immune responses designed for multicellular parasite infections
  • IgE/FcεRI binding has the highest binding affinity, “irreversible”
  • Mast cells also express FcγRIIB ( Inhibitory signal; IgG shots for allergy )
27
Q

Topic 14

Sensitization of Mast Cells By Inhaled Allergens

  • Pollen activates antigen-specific ____ cells
  • Tfh2 cells activates __ cells to recreate ___
  • IgE binds to _____ and arms mast cells
Bank:
IgE
Tfh2
B
T
Fc( epsilon )
A

Sensitization of Mast Cells By Inhaled Allergens

  • Pollen activates antigen-specific Tfh2 cells
  • Tfh2 cells activates B cells to recreate IgE
  • IgE binds to Fc( epsilon ) and arms mast cells
28
Q

Topic 14

IgE Production

  • Basophils Drives ___ Differentiation by making ____
  • TH2 helps naïve __ cell to develop to ___, producing plasma cells by isotype switching
  • IgE binds to ___ receptors on mast cells
Bank:
 IL-4
TH2
FcεR1
B
T
IgE
IgG
A

IgE Production

  • Basophils Drives TH2 Differentiation by making IL-4
  • TH2 helps naïve B cell to develop to IgE, producing plasma cells by isotype switching
  • IgE binds to FcεR1 receptors on mast cells
29
Q

Topic 14

Sensitized Mast Cells Ready for Parasite Re-infection or Allergen

  • ____ = normal response
  • _____ = when the receptors get confused and think something is a parasite response

Bank:
Allergic
Anti-parasite

A

Sensitized Mast Cells Ready for Parasite Re-infection or Allergen

  • Anti-parasite = normal response
  • Allergic = when the receptors get confused and think something is a parasite response
30
Q

Topic 14

Sensitized Mast Cell Degranulates When Parasites or Allergens Appear Again

  • The allergen binding will cross link and send the signal to the ______
A

Sensitized Mast Cell Degranulates When Parasites or Allergens Appear Again

  • The allergen binding will cross link and send the signal to the cytoplasm
31
Q

Topic 14

Mast Cell Degranulation

Resting mast cell: contains granules containing ____

Activated mast cell: multivalent antigen cross-links bound ___ antibody, chasing release of granule contents

Bank:
IgE
IgG
histidine

A

Mast Cell Degranulation

Resting mast cell: contains granules containing histidine

Activated mast cell: multivalent antigen cross-links bound IgE antibody, chasing release of granule contents

32
Q

Topic 14

Mast Cells Release Inflammatory Mediators in Two Phases

Phase I: Immediate phase

  • ____ remodel connective tissue matrix
  • _____ kill parasites
  • _____ promote inflammation

Phase II: Late phase

  • _____ stimulate and amplify Th2 cell response and promote eosinophil production and activation
  • ______ attract monocytes, macrophages, and neutrophils
  • _____ cause smooth muscle contraction and attract leukocytes
Bank:
Chemokines
Cytokines
Cytokines
Enzymes
Lipid mediators
Toxic mediators
A

Mast Cells Release Inflammatory Mediators in Two Phases

Phase I: Immediate phase

  • Enzymes remodel connective tissue matrix
  • Toxic mediators kill parasites
  • Cytokines promote inflammation

Phase II: Late phase

  • Cytokines stimulate and amplify Th2 cell response and promote eosinophil production and activation
  • Chemokine attract monocytes, macrophages, and neutrophils
  • Lipid mediators cause smooth muscle contraction and attract leukocytes
33
Q

Topic 14

_____ Permanently
Inactivates
_____
Synthesis

A

Aspirin Permanently
Inactivates
Prostaglandin
Synthesis

34
Q

Topic 14

Eosinophils

  • Immidiate response involves mast cells and ___ antibodies
  • ____ reactions = eosinophils (can produce toxic substances that make the reaction worse)
  • More involved in ____ allergic reactions
Bank:
IgE
IgG
Mild
Severe
Chronic
Isolated
A

Eosinophils

  • Immidiate response involves mast cells and IgE antibodies
  • Severe reactions = eosinophils (can produce toxic substances that make the reaction worse)
  • More involved in chronic allergic reactions
35
Q

Topic 14

Eosinophils Release Inflammatory Mediators in Two Phases

Phase I: Immediate phase

  • ____ kill parasites and remodels connective tissue matrix
  • _____ kill parasites and has an antiviral effect by degrading RNA

Phase II: Late phase

  • _____ amplify eosinophil production and activates eosinophils
  • ______ promote an influx of leukocytes
  • ______ attract and activate neutrophils and platelets and increase the synthesis of lipid mediators
Bank:
Chemokines
Cytokines
Enzymes
Lipid mediators
Toxins
A

Eosinophils Release Inflammatory Mediators in Two Phases

Phase I: Immediate phase

  • Enzymes kill parasites and remodels connective tissue matrix
  • Toxins kill parasites and has an antiviral effect by degrading RNA

Phase II: Late phase

  • Cytokines amplify eosinophil production and activates eosinophils
  • Chemokines promote an influx of leukocytes
  • Lipid mediators attract and activate neutrophils and platelets and increase the synthesis of lipid mediators
36
Q

Topic 14

Common Allergens Share Similar Structure
as the _____ Antigen

  • this is why our bodies think that certain allergens are parasites
A

Common Allergens Share Similar Structure
as the Helminth Antigen

  • this is why our bodies think that certain allergens are parasites
37
Q

Topic 14

Allergic Reactions Can Be Tested using the peak expiratory flow rate (PEFR)

  • there is a dip in the PEFR at about the __ minute mark, with it peaking between __ and __ (begins late phase) hours after exposure
  • another dip at ~ __ hours after exposure
Bank:
15
30
45
1
3
6
9
12
A

Allergic Reactions Can Be Tested using the peak expiratory flow rate (PEFR)

  • there is a dip in the PEFR at about the 30 minute mark, with it peaking between 1 and 6 (begins late phase) hours after exposure
  • another dip at ~ 9 hours after exposure
38
Q

Topic 14

Allergic Reactions Vary Depending on the route the allergens introduced

  • ____ system—-Systemic Anaphylaxis
  • ____ system—-Rhinitis or Asthma
  • ____—-Hives, dermatitis
  • ____ tract—-Food allergy
Bank:
Circulation
Gastrointestinal
Respiratory
Skin
A

Allergic Reactions Vary Depending on the route the allergens introduced

  • Circulation system—-Systemic Anaphylaxis
  • Respiratory system—-Rhinitis or Asthma
  • Skin—-Hives, dermatitis
  • Gastrointestinal tract—-Food allergy
39
Q

Topic 14

Systemic Anaphylaxis

  • ____ borne allergens
  • ____ shock
    - ____ vascular permeability
    - Causes smooth muscle contraction
    - ____ in blood pressure
Bank:
Anaphylactic
Blood
Increases
Increases
Decreases 
Decreases
A

Systemic Anaphylaxis

  • Blood borne allergens
  • Anaphylactic shock
    - Increases vascular permeability
    - Causes smooth muscle contraction
    - Decreases in blood pressure
40
Q

Topic 14

____ Is Needed For
Sensitive Patients
- ____ can reverse reactions caused by mast cells

[Same answer]

A

Epinephrine Is Needed For
Sensitive Patients
- Epinephrine can reverse reactions caused by mast cells

41
Q

Topic 14

Rhinitis & Asthma Are
Caused by Inhaled Allergens

  • Allergic ____ (hay fever) - mild allergies to inhaled antigens causing sneezing and runny nose.
  • Allergic ____ - triggered by activation of submucosal ____ cells in the lower airways.
Bank:
asthma
rhinitis
B
T
mast
A

Rhinitis & Asthma Are
Caused by Inhaled Allergens

  • Allergic rhinitis (hay fever) - mild allergies to inhaled antigens causing sneezing and runny nose.
  • Allergic asthma - triggered by activation of submucosal mast cells in the lower airways.
42
Q

Topic 14

Asthma

  • ____ Asthma: degranulation of ____ cells in the lower airways of respiratory tract; short of breath, wheezing; affects 130 million people
  • ____ Asthma: develops in the ____ of allergen; sensitive to other stimuli; airway occluded by plugs of mucus; eosinophils involved.
Bank: 
Allergic
Chronic
B
T
mast
presence
absence
A

Asthma

  • Allergic Asthma: degranulation of Mast cells in the lower airways of respiratory tract; short of breath, wheezing; affects 130 million people
  • Chronic Asthma: develops in the absence of allergen; sensitive to other stimuli; airway occluded by plugs of mucus; eosinophils involved.
43
Q

Topic 14

Allergic Reactions in the Skin

  • ____ (hives) - activation of mast cells in the skin to release histamine.
  • ____ - activation of mast cells deeper in the subcutaneous tissue leading to more diffuse swelling.
  • ____ dermatitis (eczema) - more prolonged allergic reaction leading to chronic and itching skin rash.

Bank:
Angioedema
Apotic
Urticaria

A

Allergic Reactions in the Skin

  • Urticaria (hives) - activation of mast cells in the skin to release histamine.
  • Angioedema - activation of mast cells deeper in the subcutaneous tissue leading to more diffuse swelling.
  • Apotic dermatitis (eczema) - more prolonged allergic reaction leading to chronic and itching skin rash.
44
Q

Topic 14

Food Allergies

  • ___ is made against an extremely small proportion of food proteins.
  • With food allergies, the allergen crosses the gut wall and activates ____ cells via IgE.
  • Fluid leaves the ____ and passes into the lumen of the gut.
Bank: 
IgE
IgG
B
T 
mast
blood
fluid
A

Food Allergies

  • IgE is made against an extremely small proportion of food proteins.
  • With food allergies, the allergen crosses the gut wall and activates mast cells via IgE.
  • Fluid leaves the blood and passes into the lumen of the gut.
45
Q

Topic 14

Hygiene Hypothesis of Allergy

  • Children exposed to farm environment prenatally or neonatally are ____ likely to suffer from allergic problems.
  • ____ exposure = less the immune system is used to fighting
Bank:
More
More
Less
Less
A

Hygiene Hypothesis of Allergy

  • Children exposed to farm environment prenatally or neonatally are less likely to suffer from allergic problems.
  • Less exposure = less the immune system is used to fighting
46
Q

Topic 14

Treatments of Allergic Reactions (4)

  • ____
  • ____
  • ____
  • ____?
A

Treatments of Allergic Reactions (4)

  • Prevention
  • Drugs
  • Immunotherapy
  • Parasite treatment?
47
Q

Topic 14

Drug Treatment of Type I Hypersensitivity

  • ____: tightens the cell wall
A

Drug Treatment of Type I Hypersensitivity

  • Epinephrine: tightens the cell wall
48
Q

Topic 14

Anti-Allergy Immunotherapy

Anti-IgE: Therapeutic anti-IgE binds to ___ and prevents it from binding Fc(epsilon)RI and activating the ___ cell

IgG4: An immune complex containing ____ bound to Fc(lambda) RIIB and ____ bound to Fc(lambda) RIIA –> the macrophage ceases its inflammatory response

Bank:
IgE
IgG
B
T 
mast
IgG4
IgG1
A

Anti-Allergy Immunotherapy

Anti-IgE: Theraputic anti-IgE binds to IgE and prevents it from binding Fc(epsilon)RI and activating the mast cell

IgG4: An immune complex containing IgG4 bound to Fc(lambda) RIIB and IgG1 bound to Fc(lambda) RIIA –> the macrophage ceases its inflammatory response

49
Q

Topic 14

Can We Use Controlled and Deliberate Helminth Infection
to Treat Severe Allergic Conditions?

A

Yes, looks like it!

50
Q

Topic 14

Type II Hypersensitivity

  • Caused by ____ specific for altered components of host cells.
  • Creates new ____ that stimulate IgG
  • Leads to ____ and ADCC
  • Activates the ____ system
Bank:
antibodies
complement
epitopes
phagocytosis
A

Type II Hypersensitivity

  • Caused by antibodies specific for altered components of host cells.
  • Creates new epitopes that stimulate IgG
  • Leads to phagocytosis and ADCC
  • Activates the complement system
51
Q

Topic 14

Penicillin Modifies
____

A

Penicillin modifies
red blood cells

(example of type II hypersensitivity)

52
Q

Topic 14

Penicillin modified red blood cells induce ___ or ___ production

A

Penicillin modified red blood cells induce IgG or IgE production

53
Q

Topic 14

ABO Blood Group RBC antigens

  • Blood type __ individuals have glycosyltransferase A, so A antigen
  • __ individuals have glycosyltransferase B, so B antigen
  • __ individuals have no glycosyltransferase, so O (H) antigen (no A or B antigen)

Bank:
A
B
O

A

ABO Blood Group RBC antigens

  • Blood type A individuals have glycosyltransferase A, so A antigen
  • B individuals have glycosyltransferase B, so B antigen
  • O individuals have no glycosyltransferase, so O (H) antigen (no A or B antigen)
54
Q

Topic 14

Type III Hypersensitivity
(Immune Complexes)

  • _____ aggregates of immune complexes fix complement effectively, therefore are quickly cleared by phagocytosis
  • ____ immune complexes in circulation are not cleared out due to less efficient complement fixation
  • They deposit at blood vessel wall and cause ____ reaction (Type III hypersensitivity)
  • Type III hypersensitivity may not require ____
Bank: 
inflammatory
larger
sensitization
small
A

Type III Hypersensitivity
(Immune Complexes)

  • Larger aggregates of immune complexes fix complement effectively, therefore are quickly cleared by phagocytosis
  • Small immune complexes in circulation are not cleared out due to less efficient complement fixation
  • They deposit at blood vessel wall and cause inflammatory reaction (Type III hypersensitivity)
  • Type III hypersensitivity may not require sensitization
55
Q

Topic 14

Size of the immune complex depends on the relative concentration of soluble ____ and ____

A

Size of the immune complex depends on the relative concentration of soluble antigen and antibody

56
Q

Topic 14

____ ____: Local deposition of immune complex

A

Arthurs Reaction: Local deposition of immune complex

57
Q

Topic 14

Serum Sickness

  • High dose i.v. injection of soluble foreign ____ induces immune complex ____ at tissues
  • The deposition induces ____ responses

Bank:
antigens
deposition
inflammatory

A

Serum Sickness

  • High dose i.v. injection of soluble foreign antigens induces immune complex deposition at tissues
  • The deposition induces inflammatory responses
58
Q

Topic 14

Farmer’s Lung

  • ___ antibodies combine with the inhaled allergen to form immune complexes in the walls of the alveoli in the lungs, inducing local inflammation
  • This causes fluid, protein and cells to accumulate in the alveolar wall which slows ____ and compromises the function of
    the lung.
Bank:
IgA
IgE
IgG
blood-blood interchange
blood-gas interchange
blood-muscle interchange
A

Farmer’s Lung

  • IgG antibodies combine with the inhaled allergen to form immune complexes in the walls of the alveoli in the lungs, inducing local inflammation
  • This causes fluid, protein and cells to accumulate in the alveolar wall which slows blood-gas interchange and compromises the function of
    the lung.
59
Q

Topic 14

Type IV Hypersensitivity

  • Reactions mediated by antigen-specific (____) effector __ cells: TH-1, TH-2, TC
  • Takes 1-3 days to develop
    (_____)
  • Involves ____
  • Examples
    tuberculin test (TB): TH-1
    ____: TC, TH-1
    Nickel allergy
Bank: 
B
Delayed-type hypersensitivity (DTH)
macrophages
poison ivy
sensitized
T
A

Type IV Hypersensitivity

  • Reactions mediated by antigen-specific (sensitized) effector T cells: TH-1, TH-2, TC
  • Takes 1-3 days to develop
    (Delayed-type hypersensitivity (DTH))
  • Involves macrophages
  • Examples
    tuberculin test (TB): TH-1
    poison ivy: TC, TH-1
    Nickel allergy
60
Q

Topic 14

Contact Hypersensitivity

  • Takes place in the skin after contact with allergen (____)
  • Caused by highly reactive small molecules that easily penetrate skin and form complex with self protein, like a hapten/_____
    Intracellular: _____ T cells
    Extracellular: _____ T cells
  • Sensitized (____) T cells activate keratinocytes to produce pro-inflammatory cytokines and cause local inflammation
  • Poison ivy, coins, jewelry, some other metallic objects containing ____
Bank:
allergic contact dermatitis
CD4+
CD8+
conjugate
copper
memory
nickel
A

Contact Hypersensitivity

  • Takes place in the skin after contact with allergen (Allergic contact dermatitis_
  • Caused by highly reactive small molecules that easily penetrate skin and form complex with self protein, like a hapten/conjugate
    Intracellular: CD8+ T cells
    Extracellular: CD4+ T cells
  • Sensitized (memory) T cells activate keratinocytes to produce pro-inflammatory cytokines and cause local inflammation
  • Poison ivy, coins, jewelry, some other metallic objects containing nickel
61
Q

Topic 14

Metal ____ modifies self protein and create novel epitope,
which stimulates T cell allergic reactions

A
Metal Nickel (Ni) modifies self protein and create novel epitope, 
which stimulates T cell allergic reactions
62
Q

Topic 14

Allergic Contact Dermatitis

Urushoil oil (Pentacacatechol) from leaf or root of ____ penetrates skin

- Bind to \_\_\_\_ protein, creates novel epitope for CD4+ TH-1 cells. 
 - Bind to \_\_\_\_ protein creates novel epitope for CD8+ TC cells.
Bank:
extracellular
intracellular
maple tree
poison oak
A

Allergic Contact Dermatitis

Urushoil oil (Pentacacatechol) from leaf or root of poison oak penetrates skin

- Bind to extracellular protein, creates novel epitope for CD4+ TH-1 cells. 
 - Bind to intracellular protein creates novel epitope for CD8+ TC cells.